首页> 外文期刊>Journal of Chemometrics >Compressed images for affinity prediction (CIFAP): a study on predicting binding affinities for checkpoint kinase 1 protein inhibitors
【24h】

Compressed images for affinity prediction (CIFAP): a study on predicting binding affinities for checkpoint kinase 1 protein inhibitors

机译:压缩图像的亲和力预测(CIFAP):预测关卡激酶1蛋白抑制剂的结合亲和力的研究

获取原文
获取原文并翻译 | 示例
           

摘要

Analyses of known protein-ligand interactions play an important role in designing novel and efficient drugs, contributing to drug discovery and development. Recently, machine learning methods have proven useful in the design of novel drugs, which utilize intelligent techniques to predict the outcome of unknown protein-ligand interactions by learning from the physical and geometrical properties of known protein-ligand interactions. The aim of this study is to work through a specific example of a novel computational method, namely compressed images for affinity prediction (CIFAP), in which binding affinities for structurally related ligands in complexes with human checkpoint kinase 1 (CHK1) are predicted. The CIFAP algorithm presented here relates published pIC50 values of 57 compounds, derived from a thienopyridine pharmacophore, in complexes with CHK1 to their two-dimensional (2D) electrostatic potential images compressed in orthogonal dimensions. Patterns obtained from the 2D images are then used as inputs in regression and learning algorithms such as support vector regression (SVR) and adaptive neuro-fuzzy inference system (ANFIS) methods to validate the experimental pIC_(50) values. This study revealed that the 2D image pixels in the vicinity of bound ligand surfaces provide more relevant information to make correlations with the empirical pIC_(50) values. As compared with ANFIS, SVR gave rise to the lowest root mean square errors and the greatest correlations, suggesting that SVR could be a plausible choice of machine learning methods in predicting binding affinities by CIFAP.
机译:已知蛋白质-配体相互作用的分析在设计新型高效药物中起着重要作用,有助于药物的发现和开发。最近,机器学习方法已被证明可用于新型药物的设计,该药物利用智能技术通过从已知蛋白质-配体相互作用的物理和几何性质中学习来预测未知蛋白质-配体相互作用的结果。这项研究的目的是通过一种新颖的计算方法的特定示例进行工作,即用于亲和力预测的压缩图像(CIFAP),其中预测与人检查点激酶1(CHK1)形成复合物的结构相关配体的结合亲和力。此处介绍的CIFAP算法将与噻吩并吡啶药效团与CHK1配合使用的57种化合物的公开pIC50值与在正交维度上压缩的二维(2D)静电势图像相关联。从2D图像获得的图案然后用作回归和学习算法(例如支持向量回归(SVR)和自适应神经模糊推理系统(ANFIS)方法)的输入,以验证实验pIC_(50)值。这项研究表明,结合的配体表面附近的2D图像像素提供了更多相关信息,以与经验pIC_(50)值相关。与ANFIS相比,SVR产生了最低的均方根误差和最大的相关性,这表明SVR在通过CIFAP预测结合亲和力方面可能是机器学习方法的合理选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号